Excess Treatment-Related Mortality in Obese Children and Adolescents with Acute Myeloid Leukemia on AAML0531: A Report from the Children's Oncology Group

被引：1
|
作者：
Sung, Lillian [1 ]
Gerbing, Robert [2 ]
Alonzo, Todd A. [3 ]
Wang, Yi-Cheng [2 ]
Orgel, Etan [4 ]
Gamis, Alan S. [5 ]
Aplenc, Richard [6 ]
机构：
[1] Hosp Sick Children, Peter Gilgan Ctr Res & Learning, Toronto, ON, Canada
[2] Childrens Oncol Grp, Monrovia, CA USA
[3] Univ So Calif, Keck Sch Med, Los Angeles, CA USA
[4] Childrens Hosp Los Angeles, Childrens Ctr Canc & Blood Dis, Los Angeles, CA USA
[5] Childrens Mercy Hosp & Clin, Div Hematol Oncol Bone Marrow Transplantat, Kansas City, MO USA
[6] Childrens Hosp Philadelphia, Div Oncol & Ctr Childhood Canc Res, Philadelphia, PA USA
来源：
BLOOD | 2016年 / 128卷 / 22期
关键词：
D O I：
10.1182/blood.V128.22.2790.2790
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2790
引用
下载
收藏
页数：4
相关论文
共 50 条
  • [1] Adolescents and Young Adults (AYA) with Acute Myeloid Leukemia (AML) Have Increased Treatment-Related Mortality with Similar Outcomes - a Report from the Children's Oncology Group Trials AAML03P1 and AAML0531
    August, Keith J.
    Aplenc, Richard
    Sung, Lillian
    Raimondi, Susana C.
    Hirsch, Betsy A.
    Horan, John T.
    Alonzo, Todd A.
    Gerbing, Robert B.
    Wang, Yi-Cheng Jim
    Kahwash, Samir
    Heerema-McKenney, Amy
    Meshinchi, Soheil
    Gamis, Alan S.
    BLOOD, 2014, 124 (21)
  • [2] Phenotype in combination with genotype improves outcome prediction in acute myeloid leukemia: a report from Children's Oncology Group protocol AAML0531
    Voigt, Andrew P.
    Brodersen, Lisa Eidenschink
    Alonzo, Todd A.
    Gerbing, Robert B.
    Menssen, Andrew J.
    Wilson, Elisabeth R.
    Kahwash, Samir
    Raimondi, Susana C.
    Hirsch, Betsy A.
    Gamis, Alan S.
    Meshinchi, Soheil
    Wells, Denise A.
    Loken, Michael R.
    HAEMATOLOGICA, 2017, 102 (12) : 2058 - 2068
  • [3] Occurrence of Treatment-Related Cardiotoxicity and Its Impact on Outcomes Among Children Treated in the AAML0531 Clinical Trial: A Report From the Children's Oncology Group
    Getz, Kelly D.
    Sung, Lillian
    Ky, Bonnie
    Gerbing, Robert B.
    Leger, Kasey J.
    Leahy, Allison Barz
    Sack, Leah
    Woods, William G.
    Alonzo, Todd
    Gamis, Alan
    Aplenc, Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (01) : 12 - +
  • [4] Enhancement of Eligibility Guidelines for Gemtuzumab Ozogamicin Therapy for Childhood Acute Myeloid Leukemia: A Report from Children's Oncology Group Protocol AAML0531
    Pardo, Laura
    Brodersen, Lisa Eidenschink
    Lamba, Jatinder K.
    Alonzo, Todd A.
    Wang, Yi-Cheng
    Paine, Dana
    Gamis, Alan S.
    Kolb, E. Anders
    Pollard, Jessica A.
    Cooper, Todd M.
    Aplenc, Richard
    Meshinchi, Soheil
    Loken, Michael R.
    BLOOD, 2018, 132
  • [5] Recurrent Genetic Abnormalities Are Reflected in Phenotype at Diagnosis in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group Protocol AAML0531
    Voigt, Andrew P.
    Brodersen, Lisa Eidenschink
    Gerbing, Robert B.
    Menssen, Andrew J.
    Hirsch, Betsy A.
    Raimondi, Susana C.
    Gamis, Alan S.
    Alonzo, Todd A.
    Meshinchi, Soheil
    Loken, Michael R.
    BLOOD, 2015, 126 (23)
  • [6] Standardized costs and outcome in children treated with gemtuzumab on the AAML0531 trial: A report from the Children's Oncology Group.
    Aplenc, Richard
    Fisher, Brian
    Li, Yimei
    Alonzo, Todd Allen
    Gerbing, Robert B.
    Hall, Matt
    Arnold, Staci D.
    Huang, Yuan-Shung
    Seif, Alix Eden
    Bagatell, Rochelle
    Sung, Lillian
    Adamson, Peter C.
    Gamis, Alan S.
    Keren, Ron
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [7] Comparison of in-patient costs for children treated on the AAML0531 clinical trial: A report from the Children's Oncology Group
    Getz, Kelly D.
    Li, Yimei
    Alonzo, Todd A.
    Hall, Matthew
    Gerbing, Robert B.
    Sung, Lillian
    Huang, Yuan-Shung
    Arnold, Staci
    Seif, Alix E.
    Miller, Tamara P.
    Bagatell, Rochelle
    Fisher, Brian T.
    Adamson, Peter C.
    Gamis, Alan
    Keren, Ron
    Aplenc, Richard
    PEDIATRIC BLOOD & CANCER, 2015, 62 (10) : 1775 - 1781
  • [8] ABCB1 SNP predicts outcome in patients with acute myeloid leukemia treated with Gemtuzumab ozogamicin: a report from Children's Oncology Group AAML0531 Trial
    Rafiee, Roya
    Chauhan, Lata
    Alonzo, Todd A.
    Wang, Yi-Cheng
    Elmasry, Ahlam
    Loken, Michael R.
    Pollard, Jessica
    Aplenc, Richard
    Raimondi, Susana
    Hirsch, Betsy A.
    Bernstein, Irwin D.
    Gamis, Alan S.
    Meshinchi, Soheil
    Lamba, Jatinder K.
    BLOOD CANCER JOURNAL, 2019, 9
  • [9] Occurrence of Cardiotoxicity and the Impact on Outcomes Among Children Treated on the AAML0531 Clinical Trial: A Report from the Children's Oncology Group
    Getz, Kelly D.
    Sung, Lillian
    Ky, Bonnie
    Gerbing, Robert B.
    Leger, Kasey J.
    Barz, Allison
    Sack, Leah
    Woods, William G.
    Alonzo, Todd A.
    Gamis, Alan S.
    Aplenc, Richard
    BLOOD, 2017, 130
  • [10] ABCB1 SNP predicts outcome in patients with acute myeloid leukemia treated with Gemtuzumab ozogamicin: a report from Children’s Oncology Group AAML0531 Trial
    Roya Rafiee
    Lata Chauhan
    Todd A. Alonzo
    Yi-Cheng Wang
    Ahlam Elmasry
    Michael R. Loken
    Jessica Pollard
    Richard Aplenc
    Susana Raimondi
    Betsy A. Hirsch
    Irwin D. Bernstein
    Alan S. Gamis
    Soheil Meshinchi
    Jatinder K. Lamba
    Blood Cancer Journal, 9
12345